BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 7669638)

  • 21. A comparison of bathwater and oral delivery of 8-methoxypsoralen in PUVA therapy for plaque psoriasis.
    Cooper EJ; Herd RM; Priestley GC; Hunter JA
    Clin Exp Dermatol; 2000 Mar; 25(2):111-4. PubMed ID: 10733632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spectrofluorimetric determination of 5-methoxypsoralen pharmacokinetic in patients' serum.
    Saïd A; Makki S; Muret P; Toubin G; Humbert P; Millet J
    Exp Dermatol; 1997 Apr; 6(2):57-63. PubMed ID: 9209885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bath-water delivery of 8-methoxypsoralen therapy for psoriasis.
    Collins P; Rogers S
    Clin Exp Dermatol; 1991 May; 16(3):165-7. PubMed ID: 1934565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma levels of 8-methoxypsoralen following oral or bath-water treatment.
    Thomas SE; O'Sullivan J; Balac N
    Br J Dermatol; 1991 Jul; 125(1):56-8. PubMed ID: 1873204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy.
    Shephard SE; Panizzon RG
    Dermatology; 1999; 199(2):106-12. PubMed ID: 10559574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microenema of 8-methoxypsoralen in photochemotherapy of psoriasis.
    Siddiqui AH; Stolk L; Korthals Altes-Levij van Vinninghe HR; Kammeijer A; Cormane RH
    Arch Dermatol Res; 1982; 273(3-4):219-23. PubMed ID: 7165351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bath-PUVA therapy induces circulating regulatory T cells in patients with psoriasis.
    Saito C; Maeda A; Morita A
    J Dermatol Sci; 2009 Mar; 53(3):231-3. PubMed ID: 19070466
    [No Abstract]   [Full Text] [Related]  

  • 28. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
    Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
    J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PUVA-gel vs. PUVA-bath therapy for severe recalcitrant palmoplantar dermatoses. A randomized, single-blinded prospective study.
    Schiener R; Gottlöber P; Müller B; Williams S; Pillekamp H; Peter RU; Kerscher M
    Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):62-7. PubMed ID: 15752122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
    Nimkulrat P; Leenutaphong V; Sudtim S
    J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of plaque-type psoriasis with cream-PUVA therapy].
    Steinmeyer K; Grundmann-Kollmann M; Podda M; Kaufmann R
    Hautarzt; 2001 Oct; 52(10):885-7. PubMed ID: 17690819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spatial distribution of 8-methoxypsoralen penetration into human skin after systemic or topical administration.
    Grundmann-Kollmann M; Podda M; Bräutigam L; Hardt-Weinelt K; Ludwig RJ; Geisslinger G; Kaufmann R; Tegeder I
    Br J Clin Pharmacol; 2002 Nov; 54(5):535-9. PubMed ID: 12445034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides.
    Weber F; Schmuth M; Sepp N; Fritsch P
    Acta Derm Venereol; 2005; 85(4):329-32. PubMed ID: 16191854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and effectiveness of an aggressive and individualized bath-PUVA regimen in the treatment of psoriasis.
    Calzavara-Pinton PG; Ortel B; Hönigsmann H; Zane C; De Panfilis G
    Dermatology; 1994; 189(3):256-9. PubMed ID: 7949478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma levels of 8-methoxypsoralen after topical paint PUVA.
    Pham CT; Koo JY
    J Am Acad Dermatol; 1993 Mar; 28(3):460-6. PubMed ID: 8445063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of severe recalcitrant dermatoses of the palms and soles with PUVA-bath versus PUVA-cream therapy.
    Grundmann-Kollmann M; Behrens S; Peter RU; Kerscher M
    Photodermatol Photoimmunol Photomed; 1999 Apr; 15(2):87-9. PubMed ID: 10321522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of water temperature on photosensitization in bath-PUVA therapy with 8-methoxypsoralen.
    Gruss C; Behrens S; von Kobyletzki G; Reuther T; Husebo L; Altmeyer P; Kerscher M
    Photodermatol Photoimmunol Photomed; 1998; 14(5-6):145-7. PubMed ID: 9826883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics and dose-response of photosensitivity in cream psoralen plus ultraviolet A photochemotherapy: comparative in vivo studies after topical application of three standard preparations.
    Grundmann-Kollmann M; Tegeder I; Ochsendorf FR; Zollner TM; Ludwig R; Kaufmann R; Podda M
    Br J Dermatol; 2001 May; 144(5):991-5. PubMed ID: 11359386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-Methoxy psoralen, etretinate, and UVA for psoriasis.
    Lane-Brown M
    Int J Dermatol; 1987 Dec; 26(10):655-9. PubMed ID: 3429102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment.
    Tanew A; Kipfelsperger T; Seeber A; Radakovic-Fijan S; Hönigsmann H
    J Am Acad Dermatol; 2001 Apr; 44(4):638-42. PubMed ID: 11260539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.